Glenmark Pharmaceuticals rises as its arm to launch Sodium Phosphates Injection

Glenmark Pharmaceuticals rises as its arm to launch Sodium Phosphates Injection

Mumbai, February 27 (Udaipur Kiran): Glenmark Pharmaceuticals is currently trading at Rs. 2134.75, up by 7.60 points or 0.36% from its previous closing of Rs. 2127.15 on the BSE. The scrip opened at Rs. 2127.15 and has touched a high and low of Rs. 2147.00 and Rs. 2119.20 respectively. So far 12702 shares were traded … Read more

Glenmark Pharmaceuticals trades higher on entering into agreement with Eris Oaknet Healthcare

glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets

Glenmark Pharmaceuticals is currently trading at Rs. 421.00, up by 4.55 points or 1.09% from its previous closing of Rs. 416.45 on the BSE. The scrip opened at Rs. 420.00 and has touched a high and low of Rs. 421.75 and Rs. 414.70 respectively. So far 7135 shares were traded on the counter. The BSE … Read more

Glenmark Pharmaceuticals rises on launching first triple FDC Teneligliptin with Pioglitazone and Metformin

glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets

Glenmark Pharmaceuticals is currently trading at Rs. 415.50, up by 6.30 points or 1.54% from its previous closing of Rs. 409.20 on the BSE. The scrip opened at Rs. 411.45 and has touched a high and low of Rs. 417.55 and Rs. 409.80 respectively. So far 3745 shares were traded on the counter. The BSE … Read more

Glenmark Pharmaceuticals rises on getting USFDA’s nod for Sodium Phenylbutyrate Tablets

glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets

Glenmark Pharmaceuticals is currently trading at Rs. 418.30, up by 5.10 points or 1.23% from its previous closing of Rs. 404.40 on the BSE. The scrip opened at Rs. 412.15 and has touched a high and low of Rs. 418.00 and Rs. 412.15 respectively. So far 8167 shares were traded on the counter. The BSE … Read more

Glenmark gains on becoming first company in India to launch Teneligliptin + Dapagliflozin Fixed Dose Combination

glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets

Glenmark Pharmaceuticals is currently trading at Rs. 398.00, up by 2.60 points or 0.66% from its previous closing of Rs. 395.40 on the BSE. The scrip opened at Rs. 396.60 and has touched a high and low of Rs. 403.00 and Rs. 392.65 respectively. So far 21781 shares were traded on the counter. The BSE … Read more

BREAKING NEWS:
Jio’s Exciting 3 Plans: Unlimited Calling and Data for 90 Days! Thousands of Electric Cars Sold in May: Top 5 Revealed Big iPhone 17 Pro deal: Amazon Sale starts July 4!